Understanding how metabolism affects Alzheimer's disease through gene regulation

Gene regulatory mechanisms connecting metabolism and Alzheimer’s Disease

NIH-funded research University of Utah · NIH-10660149

This study is looking at how our body's metabolism might be linked to Alzheimer's disease by exploring certain genes that could help us understand the condition better, with the goal of finding new ways to slow it down or prevent it.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Utah NIH-funded
Lab location1 site (Salt Lake City, United States)
Project IDNIH-10660149 on NIH RePORTER

What this research studies

This research investigates the connection between metabolism and Alzheimer's disease by focusing on gene regulatory mechanisms. It aims to identify specific cis-regulatory elements (CREs) that play a crucial role in gene expression related to Alzheimer's. Using an innovative approach called pPR-Seq, the study will profile active CREs and their interactions with genes in the brain. By uncovering these connections, the research hopes to find new ways to slow or prevent the progression of Alzheimer's disease.

Who could benefit from this research

Good fit: Ideal candidates for this research are adults aged 21 and older who are at risk for or diagnosed with Alzheimer's disease.

Not a fit: Patients with early-stage Alzheimer's disease or those without any genetic predisposition to the condition may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or slowing the progression of Alzheimer's disease.

How similar studies have performed: Other research has shown promise in exploring the relationship between metabolism and Alzheimer's disease, but this specific approach is innovative and largely untested.

Where this research is happening

Salt Lake City, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.